TB Research

Case Report: A novel <i>IKBKB</i> variant (c.1705G>T) is associated with immune dysregulation and disseminated tuberculosis

Arce-Estrada GE, Rodríguez-Morales M, Scheffler-Mendoza SC, Sáez-de-Ocariz M, Berrón-Ruiz L, Espinosa-Padilla SE, Contreras-Verduzco FA

Frontiers in immunology · 2025-03

Abstract

Objective To describe a novel IKBKB variant linked to immune dysregulation and disseminated tuberculosis, alongside a review of pathogenic variants to outline their phenotypic spectrum. Material and methods Observational case report and literature review. Results A five-month-old girl from an endogamous Mexican population developed symptoms suggestive of Kawasaki disease which progressed to hemophagocytic syndrome. Mycobacterium bovis was found in her skin, blood, and bone marrow. She had received the Bacillus Calmette-Guérin (BCG) vaccine on the second day of life. Genetic testing revealed a homozygous pathogenic variant (PV) in the IKBKB gene (c.1705G>T, p.Glu569*). Both parents were heterozygous. Fourteen publications were found, encompassing 33 patients with 14 different PV, including the case described in this work. Discussion Hypogammaglobulinemia, candidiasis and mycobacterial infections were common in most cases identified. Our case is unique in presenting with Kawasaki disease, hemophagocytic syndrome, and mycobacteria from skin, blood, and bone marrow. Conclusions We identified a novel homozygous PV in the IKBKB gene, highlighting new clinical manifestations.

MeSH terms

  • Humans
  • Mycobacterium bovis
  • Tuberculosis
  • Mucocutaneous Lymph Node Syndrome
  • Genetic Predisposition to Disease
  • Homozygote
  • Mutation
  • Infant
  • Female
  • Lymphohistiocytosis, Hemophagocytic
  • I-kappa B Kinase